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Relation between BCG coverage rate and COVID-19 infection worldwide
To The Editor:
The available numbers on COVID-19 have shown a huge difference
in incidence rates worldwide [1]. The explanation for these differences
is certainly multifactorial and more time is needed for accurate data
analysis and to a complete understanding. However, we can assume
that there are factors directly influencing COVID-19 incidences, such as
population age or mitigation measures. In this new disease, the initial
immunization rate is 0. Still, can we hypothesize that vaccination
coverage, resulting from each country vaccination program, can influ-
ence immunological status in such a way that it modifies COVID-19
spread? We analyzed data on vaccination coverage rates, per vaccine, in
countries all over the World. The data included BCG, DTP, HEPB, HIB,
MCV, PCV, ROTA, RCV and Polio coverage in the years of 2018, 2008,
1998 and 1988 [2]. A significant moderate negative correlation be-
tween BCG coverage and the number of COVID-19 cases per million
inhabitants was found, using a partial correlation analysis, adjusted for
population age and including data of 125 countries (Table 1). The
analysis per world regions showed a significant negative correlation in
the Western Europe countries. The remaining vaccines coverage
showed no significant correlation with COVID-19 infection rates.
United States (US) data, per state, showed no correlation between
vaccination coverage rates and COVID-19 cases [3].
We also found an association between national BGC immunization
programs and a lower rate of COVID-19 infection. BCG is not covered
by national vaccination programs in several countries. BCG is not re-
commended for generalized use in the US. Similarly, in Italy BCG was
never part of the national vaccination plan, and Spain stopped BCG
systematic immunization in 1981, Germany in 1998 and United
Kingdom in 2005–7[4]. We leave the explanation for these findings
open and underline that they do not seem to be random at all. Our
results could open doors for future research both in the field of the
development of a new vaccine for COVID-19 and in a more complex
analysis on the effect of vaccination coverage on emerging viral dis-
eases.
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Table 1
BCG immunization coverage per country versus CODIV-19 cases and deaths per
per million inhabitants worldwide.
Immunization coverage Cases/1 M population Deaths/1 M population
BCG2018 −0.396 (0.000) −0.252 (0.004)
BCG2008 −0.423 (0.000) −0.282 (0.001)
BCG1998 −0.380 (0.000) −0.260 (0.003)
BCG1988 −0.183 (0.040) −0.129 (0.149)
Pearson Correlation (sig. 2-tailed).
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